Asthma, a highly prevalent chronic inflammatory disease of the airways, is characterized by a variable degree of airflow obstruction, edema, and bronchial hyper responsiveness caused by chronic exposition to allergens or associated to other diseases such as gastro esophageal reflux. The complex genetic actions and environmental triggers intric...

Chronic cough-variant asthma (CCVA) is a very common subtype of bronchial asthma among children population. This condition often manifests with acute cough, chronic cough, and intractable cough, especially at night. It has been reported that CCVA contributed 24.0% to 33.3% of chronic cough cases, and children alone accounted for the incidence o...

JAMA Network: Published on June, 2022Montelukast, the most widely used leukotriene-modifying agent (LTMA), is a selective leukotriene receptor antagonist and is currently indicated for prophylactic and chronic treatment of asthma, relief of symptoms of allergic rhinitis, and acute prevention of exercise-induced bronchoconstriction.This propensi...

The COVID-19 pandemic has presented challenges in management and follow-up in common respiratory diseases such as asthma. This review will discuss the current recommendations regarding asthma and COVID-19 based on best available evidence at this time. RemoveAvailable Brand

Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). It is also used before exercise to prevent breathing problems during exercise (bronchospasm).Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose).  Common Ast...

Montelukast is used to control and prevent symptoms caused by asthma. It is also used before exercise to prevent breathing problems during exercise (bronchospasm).Asthma Symptoms:Montelukast recommended dose is once a day in the evening and it’s important to take it regularly even when patient have no symptoms.Note: Montelukast is not a rescue medi...